TDAC CEO buys 53,395 company warrants

Translational Development Acquisition Corp. director and CEO Michael B. Hoffman bought 53,395 warrants in an open-market transaction.

Rhea-AI Filing Summary

Translational Development Acquisition Corp. director and CEO Michael B. Hoffman bought 53,395 warrants in an open-market transaction. The warrants were purchased at a weighted average price of about $0.79 per warrant, for aggregate proceeds of $42,280.50. Each warrant entitles the holder to acquire one Class A ordinary share at an exercise price of $11.50 per share. The warrants become exercisable 30 days after completion of the company’s initial business combination and expire five years after that business combination, or earlier upon redemption or liquidation. Following this transaction, Hoffman directly holds 53,395 warrants.

Insider Trade Summary

Net Buyer: 53,395 shares

Net Buy 1 txn

Insider Hoffman Michael B

Role Chairman and CEO

Bought 53,395 shs ($42K)

Type	Security	Shares	Price	Value
Purchase	Warrants	53,395	$0.7918	$42K

Holdings After Transaction: Warrants — 53,395 contracts (Direct)

Footnotes (2)

1. F1. Each warrant becomes exercisable 30 days after completion of the Issuer's initial business combination, as described in the Issuer's filings with the Securities and Exchange Commission. The warrants expire five years after completion of the Issuer's initial business combination, or earlier upon redemption or liquidation, as described in the Issuer's filings with the Securities and Exchange Commission (the "SEC")
2. F2. The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.71 to $0.9997, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of warrants purchased at each separate price within the range set forth in this footnote. For reference, aggregate proceeds were $42,280.50 and the exact weighted average price was $0.7918438056.

Key Figures

Warrants purchased: 53,395 warrants Weighted average purchase price: $0.7918 per warrant Aggregate purchase amount: $42,280.50 +3 more

6 metrics

Warrants purchased 53,395 warrants Open-market purchase on 2026-05-27

Weighted average purchase price $0.7918 per warrant Price per warrant reported in transaction details

Aggregate purchase amount $42,280.50 Total proceeds paid for warrants as noted in footnote

Exercise price $11.50 per share Warrant exercise price for Class A ordinary shares

Underlying shares 53,395 Class A shares Shares underlying the purchased warrants

Exercise window 5 years after business combination Warrant term following initial business combination

Key Terms

open-market purchase, warrants, weighted average price, Class A ordinary shares, +1 more

5 terms

open-market purchase financial

"Warrants were acquired in an open-market purchase transaction."

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

warrants financial

"Each warrant becomes exercisable 30 days after completion of the initial business combination."

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

weighted average price financial

"The price reported is a weighted average price for multiple warrant trades."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Class A ordinary shares financial

"The warrants are exercisable into Class A ordinary shares of the issuer."

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

initial business combination financial

"Each warrant becomes exercisable 30 days after completion of the issuer's initial business combination."

An initial business combination is the deal in which a special-purpose acquisition company (SPAC) merges with or acquires an operating business to bring that business onto public markets. Think of the SPAC as an empty shell that raises money from investors, then uses that cash to buy a private company—this transaction turns the private company into a public one and often changes its ownership, valuation, and access to capital, so investors should watch for shifts in risk, future growth prospects, and shareholder rights.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did TDAC Chairman and CEO Michael B. Hoffman report?

Michael B. Hoffman reported an open-market purchase of 53,395 warrants of Translational Development Acquisition Corp. He now directly holds these warrants, increasing his derivative exposure tied to the company’s Class A ordinary shares.

How much did Michael B. Hoffman pay for the TDAC warrants he purchased?

He paid aggregate proceeds of $42,280.50 for 53,395 TDAC warrants. The weighted average purchase price was approximately $0.79 per warrant, with individual trades executed between $0.71 and $0.9997 per warrant.

What do the purchased TDAC warrants held by Michael B. Hoffman represent?

Each TDAC warrant allows Michael B. Hoffman to acquire one Class A ordinary share at an exercise price of $11.50 per share. In total, his 53,395 warrants are linked to 53,395 underlying Class A ordinary shares.

When can the TDAC warrants bought by Michael B. Hoffman be exercised?

The TDAC warrants become exercisable 30 days after completion of the company’s initial business combination. Until that business combination closes and the 30-day period passes, the warrants cannot be exercised into Class A ordinary shares.

When do the TDAC warrants purchased by Michael B. Hoffman expire?

The TDAC warrants expire five years after completion of Translational Development Acquisition Corp.’s initial business combination. They may also terminate earlier if redeemed or if the company is liquidated, according to the stated terms.

Did Michael B. Hoffman buy TDAC common shares or derivatives in this Form 4 filing?

He bought warrants, which are derivative securities, not common shares directly. These warrants give him the right to purchase Class A ordinary shares later at a fixed exercise price of $11.50 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/29/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hoffman Michael B

(Last) (First) (Middle)

C/O TRANSLATIONAL DEVELOPMENT ACQ CORP.

52 E. 83RD STREET

(Street)

NEW YORK NEW YORK 10028

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Translational Development Acquisition Corp. [ TDAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrants	$11.5	05/27/2026		P		53,395		(1)	(1)	Class A ordinary shares	53,395	$0.7918(2)	53,395	D

Explanation of Responses:

1. Each warrant becomes exercisable 30 days after completion of the Issuer's initial business combination, as described in the Issuer's filings with the Securities and Exchange Commission. The warrants expire five years after completion of the Issuer's initial business combination, or earlier upon redemption or liquidation, as described in the Issuer's filings with the Securities and Exchange Commission (the "SEC")

2. The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.71 to $0.9997, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of warrants purchased at each separate price within the range set forth in this footnote. For reference, aggregate proceeds were $42,280.50 and the exact weighted average price was $0.7918438056.

	/s/ Michael B. Hoffman	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)